Ensemble Capital started to build up the position in Johnson & Johnson in Q1 2013. Since then they sold 8.28 Thousand shares. The investor completely sold their stake between Q2 2013 and Q3 2015.
Capstan Therapeutics, a San Diego, CA-based biotechnology company dedicated to advancing in vivo reprogramming of cells through RNA delivery using targeted l...
FinSMEs, 7 days agoGreenlight Capital picks up a new stake in Kenvue Inc, formerly the consumer healthcare division of Johnson & Johnson.
MarketWatch, about 1 month agoEye health products company Bausch + Lomb Corp (NYSE: BLCO ) is scheduled to release its fourth-quarter and full-year 2023 financial results on February 21, ...
Benzinga, about 2 months agoRelated Stocks: MSFT , PYPL , CVS , NEM , JNJ ,
GuruFocus, about 1 year ago